Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain.
Victoria NechesLaura Amanda Vallejo-AparicioAfisi S IsmailaAntoni Sicras MainarAram Sicras-NavarroCruz GonzálezRafael CuervoSoham ShuklaMarcos García-PeñuelaPublished in: International journal of chronic obstructive pulmonary disease (2022)
ICS withdrawal in patients with COPD receiving TT was associated with increased exacerbations, HRU, and costs compared with continuing TT, with health and economic impacts on patients and the Spanish National Healthcare System, respectively. Pneumonia and mortality rates were similar between groups.
Keyphrases
- chronic obstructive pulmonary disease
- end stage renal disease
- newly diagnosed
- cystic fibrosis
- healthcare
- public health
- chronic kidney disease
- mental health
- cardiovascular events
- quality improvement
- cardiovascular disease
- mesenchymal stem cells
- patient reported outcomes
- bone marrow
- health information
- climate change
- cell therapy
- air pollution
- human health